Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial

BACKGROUND: Ovarian stimulation (OS) for poor ovarian response (POR) patients is still a major challenge in assisted reproductive techniques. Aromatase inhibitors as co-treatment in antagonist protocol are suggested to these patients, but there are controversial reports. OBJECTIVE: To evaluate the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Moini, Ashraf, Lavasani, Zohreh, Kashani, Ladan, Mojtahedi, Maryam Farid, Yamini, Nazila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Knowledge E 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804330/
https://www.ncbi.nlm.nih.gov/pubmed/31646260
http://dx.doi.org/10.18502/ijrm.v17i9.5101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804330/
https://www.ncbi.nlm.nih.gov/pubmed/31646260
http://dx.doi.org/10.18502/ijrm.v17i9.5101

Ejemplares similares